In the BioHarmony Drug Report Database
Mavrilimumab
Mavrilimumab is an antibody pharmaceutical. It is currently being investigated in clinical studies. The pharmaceutical is active against granulocyte-macrophage colony-stimulating factor receptor subunit alpha.
Trade Name
|
|
|---|---|
Common Name
|
mavrilimumab |
ChEMBL ID
|
CHEMBL1743039 |
Indication
|
|
Drug Class
|
Monoclonal antibodies |
Image (chem structure or protein)
